Heritage Cannabis Holdings Corp TRJTF

Primary Symbol: HERTF

Healthcare Cannabis

Heritage Cannabis Holdings Corp. is a Canada-based cannabis company offering products to both the medical and recreational legal cannabis markets in Canada and the United States. It focuses on extraction and the creation of extract and extract-derivative products and brands for adult use and cannabis-based medical solutions. It has a portfolio of cannabis products under the brands Purefarma, Pura Vida, RAD, Premium 5, Thrifty, Adults Only, feelgood., the CB4 suite of medical products in Canada and ArthroCBD in the United States. In Canada, it operates through its subsidiaries, Heritage Cannabis West Corporation (Heritage West) and Heritage Cannabis East Corporation (Heritage East). Heritage West holds a Health Canada issued cultivation, processing, and medical and adult use sales license, as well as an industrial hemp license, a cannabis oil sales license, and a cannabis research license. In the United States, it operates through, Opticann Inc., an oral and topical cannabinoid company.

PINL:HERTF - Post by User

Heritage Cannabis Holdings Corp

Bullboard Posts

Comment by BobGreenfieldon Jan 04, 2020 7:53pm

28 Views

Post# 30518948

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Weak Q4 numbers then it gets better.

Kingfish ........ by saying Sharples wouldn't entertain a financing like the one JWC did with the Lind group is implying JWC executives aren't too savvy when it comes to making deals ........ financial or otherwise.

Kingfish ....... were JWC dummies in signing a deal with Heritage?

As for the Canntab thingy ...... Heritage disclosed they have stopped CBD extraction via hemp ....... so ......... how do you think that will reflect in coming quarter disclosures?

Kingfish wrote: No comment because I could care less about jwc beyond the deal with heritage. And do you really think Clint will put heritage in that type of position with financing? Come on Bob you may dislike him but he's no dummy. I mean, look at what he's been able to accomplish with the raise. Enough money to put the company well into revenue. Financing will be down the road when they are further into revenue and for other 2.0 products to be manufactured. They have the capsule angle covered with canntab... forgot about that gem eh Bobby boy. It'll likely be when there's a bigger deal on the table with cronos cosmetic line. But something tells me they won't be wasting much time with many 2.0 products, they'll be going after the larger, more profitable medical block. Time will tell. Until then keep up your positivity.

Bullboard Posts

The top 10 Canadian medical stocks